shutterstock_1169047330_markvanscyoc-1
markvanscyoc / shutterstock.com
6 September 2022Big PharmaStaff Writer

USPTO unveils tool to access key FDA data

Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
7 July 2022   The US Patent and Trademark Office and Food and Drug Administration have partnered to facilitate access to affordable drugs.
article
28 February 2023   Pharma trade body highlighted negative narratives involving continuation patents | Such IP “essential for ongoing research and development” | USPTO requested comments following criticism of patent thickets.

More on this story

Big Pharma
7 July 2022   The US Patent and Trademark Office and Food and Drug Administration have partnered to facilitate access to affordable drugs.
article
28 February 2023   Pharma trade body highlighted negative narratives involving continuation patents | Such IP “essential for ongoing research and development” | USPTO requested comments following criticism of patent thickets.

More on this story

Big Pharma
7 July 2022   The US Patent and Trademark Office and Food and Drug Administration have partnered to facilitate access to affordable drugs.
article
28 February 2023   Pharma trade body highlighted negative narratives involving continuation patents | Such IP “essential for ongoing research and development” | USPTO requested comments following criticism of patent thickets.